168 HR clonidine 0.00417 MG/HR Transdermal System [Catapres]
RxNorm concept 998673, branded drug (sbd). Prescribable name: Catapres-TTS-1, 0.1 MG/Day Weekly Transdermal System.
- RxCUI
- 998673
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/998673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
168 HR Catapres 0.00417 MG/HR Transdermal System; 168 HR Catapres-TTS-1 0.00417 MG/HR Transdermal System; 168 HR cloNIDine 0.00417 MG/HR Transdermal System [Catapres]; Catapres-TTS-1 0.1 MG/Day Weekly Transdermal Patch; Catapres-TTS-1, 0.1 MG/Day Weekly Transdermal System
Related concepts
- clonidine 0.00417 MG/HR (SCDC, consists of)
- clonidine 0.00417 MG/HR [Catapres] (SBDC, consists of)
- Transdermal System (DF, has dose form)
- Catapres (BN, has ingredient)
- 168 HR clonidine 0.00417 MG/HR Transdermal System (SCD, tradename of)
Linked data
NDCs
- 00597003134
- 82089010134
- 82089020134
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 998673 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/998673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 998673. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.